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Abstract: Bovine leukemia virus (BLV) causes Enzootic Bovine Leukosis (EBL), a persistent life-long
disease resulting in immune dysfunction and shortened lifespan in infected cattle, severely impacting
the profitability of the US dairy industry. Our group has found that 94% of dairy farms in the United
States are infected with BLV with an average in-herd prevalence of 46%. This is partly due to the
lack of clinical presentation during the early stages of primary infection and the elusive nature of
BLV transmission. This study sought to validate a near-complete genomic sequencing approach for
reliability and accuracy before determining its efficacy in characterizing the sequence identity of BLV
proviral genomes collected from a pilot study made up of 14 animals from one commercial dairy
herd. These BLV-infected animals were comprised of seven adult dam/daughter pairs that tested
positive by ELISA and qPCR. The results demonstrate sequence identity or divergence of the BLV
genome from the same samples tested in two independent laboratories, suggesting both vertical
and horizontal transmission in this dairy herd. This study supports the use of Oxford Nanopore
sequencing for the identification of viral SNPs that can be used for retrospective genetic contact
tracing of BLV transmission.
Keywords: bovine leukemia virus; retroviral evolution; proviral load; Oxford Nanopore Sequencing;
phylogenetics; targeted sequencing
1. Introduction
Enzootic bovine leukosis (EBL) is a disease caused by the retrovirus bovine leukemia
virus (BVL) and is a major economic detriment to the U.S. dairy industry. Most infected
cattle remain asymptomatic but approximately 30% develop persistent lymphocytosis and
elevated number of B-cells, while 5% of them develop B-cell leukemia/lymphosarcoma [1].
BLV pathogenesis compromises the host’s immune system, leaving the cows susceptible
to several other opportunistic pathogens, all of which might serve as a potential disease
reservoir within the herd and ultimately shorten the lifespan and productivity of the cows.
Many European countries have successfully eradicated BLV using bulk tank surveil-
lance. However, our group has found that 46% of dairy cows in 94% of dairy farms in the
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United States are infected with BLV [2], which is consistent with the reports from USDA
APHIS (https://www.aphis.usda.gov/animal_health/nahms/dairy/downloads/dairy0
7/Dairy07_is_BLV.pdf accessed on 6 January 2021). In addition to affecting the longevity
and overall health of the cows, BLV has also been found to affect milk production, which
accounts to a loss of approximately 380 USD per cow per year [3]. Detection of BLV DNA
in human blood or tumor samples has been linked to potential human health concerns,
including breast cancer [4,5].
BLV primarily infects B-cell lymphocytes, and following proviral integration, is prop-
agated through mitosis of immature B-cell progenitors. Transmission of BLV is thought
to occur through the introduction of an infected lymphocyte to the bloodstream of the
uninfected animal through milk/colostrum and blood-borne routes, including biting flies
and iatrogenic means such as shared needles and rectal palpation sleeves [6]. However,
the use of best management practices has proven to reduce within-herd prevalence of
BLV significantly [7]. Vertical transmission, in utero, during parturition, or postnatally via
colostrum administration, has also been found to contribute to 4–18% of new BLV infec-
tions [8,9]. Feeding BLV-infected unpasteurized colostrum [10] and contact with bodily
fluids in the birth canal during the delivery [11] have all been found as potential routes of
BLV transmission in neonatal calves. Lastly, viral transmission through the placenta could
result in a positive calf at birth [11].
The proviral load of infected animals may be directly correlated with the animal’s
ability to infect others, as with other retroviral diseases such as HIV [12]. In fact, a multi-
herd BLV control field trial [13] showed a reduction in the within-herd incidence of BLV
infection associated with the removal of high proviral load cattle from the herd. Antibody
detection via Agar Gel Immunodiffusion (AGID) and Enzyme-linked Immunosorbent
Assay (ELISA) are currently accepted methods used to diagnose cows but are poorly
correlated to an animal’s proviral load.
Detection of BLV proviral DNA can be accomplished through endpoint polymerase
chain reaction (PCR) with varying levels of specificity and sensitivity, depending on the de-
sign of primer sequences. Nested end-point PCRs are commonly used as a highly sensitive
method of to detect BLV proviral DNA, despite their poor specificity [12,14–16]. Quan-
titative PCR (qPCR) allows for the relative and simultaneous quantification of provirus
and host DNA with a high degree of specificity and sensitivity when used with TaqMan®
fluorophores. Our group developed the SS1 BLV proviral load qPCR multiplex assay (Cen-
tralStar Cooperative, Lansing, MI, USA) consisting of three TaqMan™ primer/probe assays
that detect the BLV pol gene, bovine β-Actin, and an internal amplification control [17–19].
Through qPCR calibration using digital droplet PCR (ddPCR) normalized DNA standards,
the SS1 assay has 100% specificity and sensitivity down to a limit of detection of 10 BLV
copies. We therefore can precisely compare the relative infectiousness between animals
over time, using the SS1 BLV proviral load qPCR multiplex assay.
To date, genetic diversity of the BLV proviral DNA has been characterized mostly
based on sequencing the envelope gene (env) either by Sanger or short-read next-generation
sequencing (NGS, Illumina) methods. Ten different genotypes have been identified so
far based on the variations within the env gene and whole genome analysis via tiled PCR
based NGS sequencing [20,21]. Previous studies agree that BLV genotypes associate with
the global geographical origin [21,22]. However, it is precarious to draw on international
BLV genetic relationships based on short and conserved genomic regions, like the env
gene. Sanger sequencing and short-read NGS have established important geographical and
molecular relationships between different viral variants, but the utility of these approaches
for elucidating the genetic structure and high-resolution genetic relationships of BLV
variants within confined populations is limited.
Single-molecule long-read sequencing methods, such as Oxford Nanopore Technolo-
gies (ONT), have enabled the sequencing of large genetic elements spanning across repeti-
tive regions and eliminate common sequencing issues encountered with other technologies,
such as high G/C content and palindromic regions. The real-time nature of ONT sig-
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nificantly reduces the long turnaround times involved in Illumina sequencing and is
considerably less expensive [23]. This methodology would also enable accurate and timely
identification of novel genotypes, which can be critical to effectively identify emerging
pathogens. This pilot study aimed to develop a molecular sequencing tool that can be
used to accurately identify new BLV variants and discern routes of transmission while
simultaneously assessing the origin, evolution, and genetic diversity of BLV within herds.
2. Results
2.1. ONT Sequencing of Long-Range PCR Amplicons from TOPO ® Vectors Containing
Bacterial Inserts
Prior to drawing conclusions on genetic variability among BLV sequences from related
animals, it was important to determine the feasibility and accuracy of the experimental
workflow and bioinformatics pipeline. PCR amplicons derived from mastitis-causing
microorganisms, ligated into TOPO ® plasmids, and verified by Sanger sequencing, were
used to evaluate the fidelity of the developed workflow. Approximately 4 kb PCR products
were generated using primers with 5′ overhangs containing the BLV_CS forward and
reverse primer sequences (Table 1, Figure S1). Secondary TOPO ® PCR products produced
from BLV_CS primers were sequenced on the ONT GridION. The resulting sequences were
compared to their corresponding Sanger sequence-verified vectors to confirm sequencing
accuracy. Both sets of vectors with their associated inserts, either a 16s rDNA sequence
from Corynebacterium bovis or Thioredoxin (TrxA) from Mycoplasma bovis, were found to be
100% identical (Figure 1) with an average 2900 × coverage (Figure S1C).Pathogens 2021, 10, x 4 of 16 
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Table 1. Sequences of primers used for amplifying the sequencing controls and BLV whole genomes. Sequences in bold
represent the BLV primer tags that were incorporated into the plasmids for use as ONT sequencing positive controls.
Primer Direction S quence Length Tm %GC Accession
BLV_CS
Forward 5′-AACCTTCTGCAAAGCGCGCAAA-3′ 22 68 50
AF033818
Reverse 5′-AAGGCGGGAGAGCCATTCATTTTC-3 24 67 50
BLV_UMN
Forward 5′-ATTGATCACCCCGGAACCCTAAC-3′ 23 66 52
AP019598.1
Reverse 5′-CTCAAAAAAGGCGGGAGAGCCATTC-3′ 25 68 52
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Table 1. Cont.








AATAGTGTATGCGGCGACCGAGT-3′ 45 69.7 51.1
M. bovis
Forward 5′-GGTTAATTCTATGCCCAGCATT-3′ 22 60 41
CP058514
Reverse 5′- TTCAGCTTCAATTGCATCCAC-3′ 21 60 43
C. bovis
Forward 5′-GTGCTTTAGTGTGTGCGGTGG-3′ 21 62 57
NZ_AENJ01000027
Reverse 5′-CGTGTCTCAGTCCCAATGTGG-3′ 21 60 57
2.2. ONT Sequencing of BLV Whole Genome Sequences
Blood samples were collected on a single date from sixteen BLV ELISA-positive adult
dam and daughter Holstein pairs from a commercial dairy farm. BLV proviral load was
determined by the SS1 BLV proviral qPCR multiplex assay (CentralStar Cooperative,
Lansing, MI, USA; Table 2) [14]. Following organic phase separation and a modified
high molecular weight (HMW) DNA extraction [24], 15 DNA samples were split into
two aliquots for PCR amplification of the BLV proviral genome. Approximately 7.5 kb
PCR products were amplified using two different sets of primer pairs developed by two
independent laboratories (Figure 2). The negative BLV SS1 sample (15.1) was consequently
removed from the study. Electrophoretograms of the amplicons generated from the two
laboratories were compared to evaluate the PCR efficacy of two different primer sets
(Figure 3). The number of trimmed reads per corresponding sequencing adaptor and the
coverage of each amplicon were evaluated to determine amplicon quality and infer the
accuracy of subsequent analyses. The differences seen with a cross-laboratory comparison
of bands could be due to read depth variability caused by amplicon quality which can
confound phylogenetic interpretation. The minimal number of reads generated from the
NTC (Non-Template Control) are likely due to barcode bleed-through resulting from the
use of single barcodes as opposed to dual barcodes [25].
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Table 2. BLV Diagnostic results of animals enrolled in this study. BLV was detected from 7 dam-daughter pairs (1–7) by SS1
qPCR. Dam 8 was BLV negative and hence was removed from subsequent sequencing.
Pair Relationship Animal ID Date of Birth Age (MO) Lact Pvl Pvl Category ELISA OD
1
Daughter 1437 25 June 2017 39 1 0.91 High 2.799
Dam 1182 11 June 2015 63 3 1.02 High 2.626
2
Daughter 1479 11 November 2017 34 1 0.37 Low 2.5
Dam 1118 29 November 2014 70 4 0.71 Low 1.287
3
Daughter 1503 21 December 2017 33 1 0.39 Low 1.704
Dam 980 6 October 2013 84 5 0.41 Low 2.266
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Table 2. Cont.
Pair Relationship Animal ID Date of Birth Age (MO) Lact Pvl Pvl Category ELISA OD
4
Daughter 1283 10 February 2016 55 2 1.18 High 1.56
Dam 909 27 February 2013 91 5 0.58 Low 2.559
5
Daughter 1523 2 February 2018 32 1 0.86 High 1.48
Dam 1280 2 February 2016 56 3 1.18 High 0.705
6
Daughter 1560 22 May 2018 28 0 0.41 Low 0.893
Dam 1303 27 March 2016 54 2 0.01 Low 0.5
7
Daughter 1513 3 January 2018 33 1 0.04 Low 0.768
Dam 1209 15 August 2015 61 3 0.87 High 2.335
8
Daughter 1606 4 April 2018 25 0 0.32 Low 2.793
Dam 1176 23 May 2015 64 3 N/A Negative 2.476
2.3. Phylogenetic Analysis of BLV Whole Genome Amplicons
Phylogenetic analysis of the ONT consensus sequences confirmed the fidelity of the
independent PCR approaches and served to assess the genetic diversity of the BLV found
within a herd. Ten out of the 14 pairs, dams 1–7 and daughters 5–8 of technical replicates
from the two laboratories matched on taxa location on the tree, solidifying the accuracy of
both PCR techniques along with the sequencing of generated amplicons (Figure 4). The
outlying samples, daughters 1, 2 and 3_UMN, were concluded as resulting from poor
coverage of those amplicons (Figure S3).Pathogens 2021, 10, x 7 of 16 
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When analyzing samples based on familial relationships, the distance between proviral
sequences from dams and daughters varies. Pair five, for example, shows sequence
identity matching based on clade location. This phylogenetic analysis also displayed viral
divergence of BLV strains in one generation. In dam/daughter pair two, the strain found in
the daughter branches off of the node shared by the dam, representing viral evolution. The
fidelity of the sequencing was confirmed via the bacterial TOPO ® plasmids, confirming
viral evolution rather than sequencing error. These results indicate that this tool is capable
of discerning the route of infection while capturing viral diversity and evolution with herds
over time.
Historically, the majority of BLV phylogenetic analyses is based solely on the env gene
sequences alone (18–20) [20–22]. Analysis of the env gene sequences extracted from the
ONT reads within this study (Figure 5) identified only six different nucleotide substitutions
which were synonymous at the amino acid level. (Figure S2). Env polyprotein was
completely conserved between the animals in the herd studied, which would significantly
limit the understanding of genetic variability between the animals in this herd if only this
BLV gene was sequenced.Pathogens 2021, 10, x 8 of 16 
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2.4. Amino Acid Substitution among BLV Positive Animals
To further compare the dam and daughter pair relationship, we performed a com-
parative amino acid analysis of six well defined proteins that might play a role in disease
dynamics (Table 3. Only the sequences generated from the BLV_CS primers were used due
to the variability in read depth and coverage seen in the BLV_UMN amplicons. Amino acid
profiles from five dams, 71%, (1, 3, 4, 6 and 7) diverged from their daughters. On the other
hand, only 2/7 (29%) of the dams and daughters shared identical amino acid profiles. The
highest number of ami o acid changes was observed between dam/ daughter pair 1 (4 AA
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substitutions), followed by the pair 7 (4 AA substitutions). At the individual protein level,
no functional SNPs could be observed in the R3 protein. Gag Pro Pol protein was the most
polymorphic with the highest number of functional SNPs (4 AA substitutions) followed
by the env polyprotein (3 AA substitutions). Despite the variation observed with the env
polyprotein, it is very interesting to note that the env protein was absolutely conserved
among the animals investigated from this herd. These results clearly show a significant
level of functional variations/modulation between the proteins and the dam daughter
pairs investigated, even within a small set of animals investigated from a single herd.
Table 3. Summary of significant amino acid changes observed in six different proteins encoded by the BLV genome
among the dam-daughter pairs sequenced using primers and conditions developed by the CentralStar laboratory. Yellow:
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3. Discussion
This study successfully utilized a bioinformatics pipeline, which included Longshot,
to call single nucleotide variants with high accuracy using whole-genome ONT data and
assemble near complete BLV proviral consensus genomes from field-collected samples. The
use of vectors with inserts verified by the Sanger sequence was able to support the integrity
of the sequencing reads developed by the ONT workflow. The BLV genome from the DNA
of whole blood samples were independently amplified twice, in two different laboratories,
following proviral load testing. Phylogenetic analysis of all resulting consensus genomes
highlighted the accuracy of the independent amplification of the proviral genomes due
to the location of the duplicated samples. Using this study data, we also defined differ-
ing transmission routes of BLV within the herd, demonstrating the value of this tool to
characterize primary transmission pathways in tested populations. The utilization of this
tool also enables further research into the tracing of genetic elements, such as the proviral
genomes of retroviruses infecting cattle.
3.1. Fidelity of Approach
Development of long-read BLV genome PCR occurred independently between the
two participating laboratories with similar objectives, to assess BLV viral transmission.
Therefore, primer design criteria, including BLV reference sequences, and PCR condition
considerations were individually optimized respective to the polymerase used. This
approach allowed for the evaluation of the robustness of the sequencing workflow and
downstream interpretation. The efficiency of PCR reactions differed resulting in variation
seen in Figure 3, corresponding to coverage achieved. However, the sequencing workflow
was able to overcome PCR inefficiencies and generate BLV proviral genome sequences.
Due to the fact that a novel library preparation and bioinformatics pipeline were used,
the fidelity of the generated reads needed to be evaluated. Oxford Nanopore Technology
sequencing has been previously criticized for its high error rates [26,27] so it was crucial
to confirm the accuracy of the resulting sequences. When comparing the sequences of the
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TOPO ® vectors with the known bacterial inserts generated by both Sanger sequencing and
ONT, 100% sequence identity was found (Figure 1). Along with proven identical sequences,
the read depth generated by our developed workflow helps overcome the high error rate,
as seen in other studies as well [28]. This is a significant obstacle to have overcome and
allows for greater insights into nucleotide substitution of large cis-acting genetic elements,
such as viral genomes.
A stepwise validation was used as a quality control check at each point along the
pipeline. A time intensive HMW DNA extraction was used to ensure high-quality DNA
and was confirmed via Nanodrop quantification and gel electrophoresis (Data not shown).
Success of the BLV PCR was evaluated with gel electrophoresis and the use of the bacterial
amplicons as positive sequencing controls. Following sequencing, reads were trimmed
and filtered with our developed bioinformatics protocol. After visualizing the generated
genomes on a phylogenetic tree and sequencing coverage plots, unreliable samples with
poor PCR product quality and low coverage were removed from future analysis to increase
the confidence of generated results (Figure S3).
3.2. Reflection of Findings and Implications for the BLV Field
Despite the high estimated prevalence of BLV within the United States and the asymp-
tomatic nature of the retrovirus infection, disease control is challenging for dairy cattle
producers. Without availability of effective treatment or vaccination programs, effective
herd management practices to break the chain of transmission is critical. Various trans-
mission routes of BLV have been reported [19–23], but it has been challenging to find
direct evidence to prove vertical transmission of the virus. We sought to develop a tool
to accurately analyze the majority of the proviral BLV genome to aid in the detection of
transmission among United States dairy farms. This method is likely to be important
for comparisons among a larger scale population of samples from varying geographical
locations. To test this approach, we selected dam and daughter pairs that were both
BLV-positive to assess the genetic identity of the proviral genomes.
On a local level, this phylogenetic analysis tool can help dairy farmers identify patterns
of BLV transmission in their herds. Due to the assortment of viral variants, dam-daughter
pairs with identical genetic sequences were concluded to likely be a result of vertical
transmission (Figure 4). However, it could be possible that another animal passed on
that exact sequence to both dam and daughter. In this study herd, only milk replacer is
used for dairy replacement calves and not colostrum. This increased the likelihood of
vertical transmission from prenatal or perinatal infection and not transmission post-calving.
Contrastingly, daughter 6, for example, was likely infected horizontally due to the greater
genetic distance between her and her mother’s strain (Figure 4). Increased rates of vertical
transmission could be decreased with do not breed orders implemented on BLV positive
dams or screening practices established before artificial insemination to ensure all bred
cows are BLV negative. Separately, increased rates of horizontal transmission could be
reduced with improved bloodborne biosecurity and better isolation practices used for
BLV-positive cattle.
Globally, BLV sequences have been mostly categorized into 10 different genotypes
based on the analysis of the env gene. The use of small proviral fragments heightens
the difficulty in drawing phylogenetic and evolutionary conclusions. In our study, an
amino acid alignment of just the env gene sequences resulted in 100% identical peptide
sequences among all samples (Figure S2). The utilization of only the env gene would not
have provided the level of resolution required to discern different routes of transmission
gained when using whole-genome sequence data. The use of entire proviral genomes
would aid in the comparison of international strains, compared to conclusions drawn
from analysis of a singular gene. Amino acid analysis of these genomes could increase
awareness of BLV pathogenesis and virulence differences among genotypes. Functional
changes resulting from mutations in Tax, Rex, and G4-along with multiple other proteins
have been previously studied, but do not align with the mutations detected in our sample
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set [29–33]. More research is needed to see if the amino acid changes listed in Table 3
impact BLV pathogenicity and transmissibility.
3.3. Application
We have developed a tool to accurately determine full-length BLV proviral genome
sequences. Within the field of BLV research in cattle, Oxford Nanopore sequencing of
whole targeted BLV whole-genome amplicons will aid in tracing spatial and temporal
modeling of infections within different herds and elucidate how cattle movement and
farm management practices affect transmission. This approach can also be used to help
resolve genetic relationships of dynamic viral populations of other pathogens such as
SARS-CoV-2. Li et al. used a similar ONT workflow with SARS-CoV-2 samples to identify
various sources and transmission patterns in China [34]. The developed workflow could
also be a valuable tool for resolving transmission patterns of Human T Lymphotropic Virus
type 1 (HTLV-1) in the central regions of Australia where disease prevalence has been
estimated at 33% within indigenous populations [35] as this virus most similarity related
to BLV. Furthermore, this tool could be used to resolve structural variation within several
genomic loci at once to extend GWAS-based approaches that identify highly associated
SNPs with a given phenotype within humans and livestock [36,37].
3.4. Limitations to This Pilot Study
The sample set used in this study is relatively small and does not represent all dairy
herds within the United States. The data collected on selected animals only displays one
snapshot within their lifetimes. A longitudinal study, including BLV-positive neonate
samples is needed to evaluate direct and temporally relevant transmission patterns. This
sampling strategy could also identify changes in the genetic diversity of the viruses within
a herd and draw more concrete conclusions on the routes of transmission.
The proviral DNA was the main sample source used, not RNA. Future research could
analyze BLV RNA transcripts to analyze strain functionality differences. The proviral DNA
was extracted using a time-intensive high molecular weight protocol. The efficacy of this
tool with extracts derived from other extraction protocols, such as column-based, needs to
be evaluated in the future. The use of less time-consuming DNA extractions would lead to
the better universal application of this tool. However, the use of the HMW protocol allows
for future direct DNA sequencing, without PCR amplification, to potentially evaluate the
differential states of DNA methylation of the BLV proviral genome, its transcription and
resulting disease dynamics [38].
4. Materials and Methods
4.1. Sample Collection
Whole blood was collected in K2 EDTA Vacutainer ® tubes (BD Vacutainer, Franklin
Lakes, NJ, USA) via coccygeal vein of eight BLV ELISA-positive dam-daughter pairs of
Holstein cows on a single date (Table 1). Samples were collected from these adult cattle
ranging from 25 to 91 months of age. Procedures for this study were reviewed and approved
by the Institutional Animal Care and Use Committee (A-3955-01, PROTO201900271) at
Michigan State University.
4.2. BLV Antibodies
Individual DHI milk samples were tested on the same date, with the Leukosis
Serum × 2 Ab test (IDEXX, Westbrook, ME, USA) to identify the BLV serostatus of the
animals at the time of bleeding. In short, milk samples were diluted in sample buffer and
pipetted into 96-well plates coated with BLV-GP51 antigen per the manufacturer’s instruc-
tions. Horseradish peroxidase-labeled bovine anti-immunoglobulin was added followed
by incubation at room temperature for 5 min. Plates were washed after each incubation
and before adding the enzyme-substrate. Reaction times were standardized using color
development of positive controls and stopped by adding 0.5 mL Sulfoamino oxidanide
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(H2NO4S). Results were reported as corrected 450 nm optical density (OD) measurements
with a corrected OD > 0.5 being considered antibody positive.
4.3. Proviral Load Diagnosis of BLV-Infected Animals
Qiagen DNeasy blood and tissue kit (Qiagen, Hilden, Germany) was used to extract
genomic DNA from whole blood collected from previously ELISA-positive cows one
week following milk ELISA screening. The SS1 qPCR assay, developed by CentralStar
Cooperative Inc., is a multiplex probe-based quantitative PCR assay that targets the BLV
proviral polymerase gene, bovine β-Actin gene, and an internal amplification spike-in
control ultramer to quantify proviral load. Briefly, 3 µL of extracted DNA, 12.5 µL of
2 × PrimeTime Gene Expression Master Mix (ThermoFisher, Austin, TX, USA), 1.25 µL
of a 20 × primer mix, 1 µL of internal spike-in control (10,000 copies/µL), and 7.25 µL of
DNA-free water were combined for each qPCR reaction. All SS1 qPCR was performed on
Applied Biosystems 7500 Fast Real-Time PCR system (FAST Real-Time PCR, Foster City, IA,
USA) with qPCR conditions as follows: 95 ◦C for 10 min, 40 × (95 ◦C for 15 sec, 60 ◦C for
1 min). BLV and bovine β-Actin (a measure of host DNA) copy numbers were derived using
a standard curve consisting of linearized plasmids containing respective target sequences
previously quantified and normalized by digital droplet PCR. Amplification efficiency
and manual thresholds were established from initial qPCR machine calibration. Proviral
Load was calculated and expressed as the ratio between proviral BLV copies and bovine
β-Actin copies.
4.4. High Molecular Weight DNA Isolation
Frozen aliquots containing 500 µL of whole blood were thawed to room temperature
and added to 1 mL of 1 × ChemCruz red cell lysis buffer (RBC: Santa Cruz Biotechnology,
Dallas, TX, USA), mixed via inverting, and incubated at room temperature on a rotisserie
tube rotator for 10 min. Samples were centrifuged at 4700× g for 5 min and the supernatant
was removed. This was repeated once more with 500 µL of RBC lysis buffer. White blood
cell pellets were resuspended in 1.5 mL of modified mammalian cell lysis buffer [26] and
incubated at 37 ◦C for 1 h prior to adding 100 µg/mL of Proteinase K (Invitrogen, Waltham,
MA, USA) and mixing with a wide bore pipette. The samples were incubated at 55 ◦C for
an hour with occasional agitation. 500 µL of buffer-saturated phenol (Invitrogen, Waltham,
MA, USA) was added at room temperature and mixed on the tube rotator for 20 min.
Organic phase separation was accomplished via centrifugation at 5000× g for 15 min. The
aqueous phase was transferred to a fresh tube and 500 µL of phenol-chloroform-isoamyl
alcohol (Acros Organics, Fair Lawn, NJ, USA) was added. After an additional phase
separation step, 0.266 volumes of 7.5 mM ammonium acetate were added to the aqueous
phase. Following a 5 min incubation at room temperature, 100% ethanol was added
followed by thorough mixing. The precipitate was collected via centrifugation at 8000× g
for 8 min at room temperature. Pellets were then dehydrated in a succession of 90% and
70% ethanol washes followed by centrifugation at 8000× g for 8 min. DNA pellets were
air-dried, eluted in 50 µL of 7.5 pH Tris-EDTA (10 mM Tris, 0.1 mM EDTA), and incubated
overnight at 4 ◦C. DNA was quantified using a Nanodrop spectrophotometer and stored at
−20 ◦C.
4.5. BLV Whole Genome PCR Amplification
4.5.1. CentralStar BLV Whole Genome PCR
To summarize, 1 µL of extracted HMW-DNA, 10 µL 5 × LongAmp Taq reaction
buffer (New England Biosystems, Ipswich, MA, UK), 1.5 µL 10 mM dNTPs, 5 µL 0.5 uM
forward and reverse primers (Table 1: BLV_CS), 2 µL LongAmp Taq DNA Polymerase,
and 22.5 µL of DNA-free water were combined for each PCR reaction. PCR was run on
an Applied Biosystems 2720 Thermal Cycler (Applied Biosystems, Waltham, MA, USA)
with conditions as follows: 94 ◦C for 30 s, 29 × (94 ◦C for 20 s, 64 ◦C for 25 s, 65 ◦C for
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6:45), 65 ◦C for 10 min. Amplicons were run out on a 1% agarose gel at 100V for an hour to
confirm amplification before library preparation.
4.5.2. University of Minnesota Veterinary Diagnostic Laboratory (MVDL) BLV Whole
Genome PCR
High molecular weight DNA extracted (as described above) was used as a template
to amplify a 7604 bp amplicon corresponding to the region, 550–8154 bp of BLV whole
genome. A 50 µL PCR reaction mixture containing 10 µL of 5 × Primestar GXL buffer,
4 µL of dNTPs (2.5 mM each), 1.5 µL (15 pm) of each primer (Table 1: BLV_UMN), 1 µL
of GXL Primestar Polymerase (Takara Bio USA Inc., Mountain view, CA, USA), 28 µL of
nuclease-free water (Ambion), along with 4 µL of the template was prepared. PCR mixture
was initially incubated for 10 s at 98 ◦C for denaturation, followed by 30 cycles of 60 ◦C
for 15 s and 68◦C for 2.5 min in a MiniAmp Plus Thermal cycler (Applied Biosystems,
Waltham, MA, USA)
4.6. Use of Vectors Containing Bacterial Inserts as Positive Sequencing Controls
To measure the fidelity of the sequencing approach, previously generated linearized
TOPO2.1 ® (Thermo Fisher Scientific, Austin, TX, USA) vectors containing bacterial genes
(Mycoplasma bovis -TrxA, Corynebacterium bovis-16 s) were used as PCR templates. Briefly, the
TOPO2.1 ® vector containing 123 bp insertion of M. bovis thioredoxin DNA was linearized
using the Sca I restriction enzyme. Topo-BLV primers (Table 1) were used to target the
5′ and 3′ ends of the linearized vector producing a 3945 bp amplicon. The linearized
vector containing the 143 bp insert of C. bovis 16s rDNA resulted in a 3967 bp amplicon
(Figure S1B). BLV_CS primers were used to amplify the primary TOPO ® amplicons prior
to Oxford Nanopore sequencing.
4.7. Bead Clean Up and Library Preparation for Oxford Nanopores Sequencing
One µL of the BLV or positive control PCR amplicon/s were electrophoretically
separated and visualized on a genomic DNA tape screen using a 4200 TapeStation (Agilent
Technologies, Santa Clara, CA, USA) for size and integrity. All amplicons, irrespective of
size, served as templates for ONT GridION sequencing. The remaining BLV and positive
control PCR amplicons were subjected to a 2 × bead clean-up using Sera-Mag Select beads
(GE HealthCare Life Sciences, Chicago, IL, USA) and eluted in a final volume of 12 µL
of nuclease-free water. The purified PCR product was finally quantified using the Qubit
1X dsDNA HS assay kit (Thermo Fisher Scientific, Waltham, MA, USA) using a Qubit
4 fluorometer (Thermo Fisher Scientific, Waltham, MA, USA) and then used for library
preparation.
Library preparation was performed using the Rapid Barcoding Sequencing Kit (SQK-
RBK004) (Oxford Nanopore Technologies, New York, NY, USA). Briefly, 7.5 µL of the
purified BLV amplicons were mixed with 2.5 µL of a fragmentation mix barcode individu-
ally (1 barcode for each sample; 12 samples were barcoded and used on a single flow cell,
wherever possible), incubated at 30 ◦C for 1 min and 80 ◦C for 1 min, followed by rapid
cooling on ice. One µL each of the 12 barcoded libraries were pooled, mixed gently with
1µL of RAP (Rapid Adapter), and incubated for 5 min at room temperature. This final
library pool (13 µL) was combined with 34 µL of sequencing buffer, 25.5 µL of loading
buffer, 2.5 µL nuclease-free water (total of 75 µL) and loaded onto a primed Flow Cell
R9.4 (FLO-MIN106D) on a GridION device and run with the SQK-RBK004_plus_Basecaller
script of MinKNOW1.5.12 software. The run was stopped after 4 h, and the flow cell was
washed with a Wash Kit (EXP-WSH002) (Oxford Nanopore Technologies, New York, NY,
USA) according to the manufacturer’s recommendation and stored at 4 ◦C for later use.
4.8. Bioinformatic Analysis of Oxford Nanopore Sequencing and Consensus Sequence Generation
The sequenced reads were base called using Guppy (4.0.14) and demultiplexed and fil-
tered with qcat v1.1.0 (ONT, https://github.com/nanoporetech/qcat accessed
on 2 June 2021) with parameters –detect-middle –min-read-length 250 –trim. Reads were
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aligned to the BLV reference genome (AP019598.1) using minimap2 v2.17 [39] and primer
sequences were trimmed from the termini of read alignments using iVAR v1.3.1 [40] with
parameter -p trim -q 1 -m 20 -s 4 -e. Consensus-level variant candidates were identified
using Medaka v1.2.2 (https://github.com/nanoporetech/medaka accessed on 2 June 2021)
using default parameter and evaluated by LongShot v0.4.1 [41] with parameter -P 0 -F -A
–no_haps before filtering with bcftools. The final consensus was generated from a filtered
VCF file and depth of coverage extracted from mapping file with samtools depth with
parameter -a -d 0.
4.9. Phylogenetic and Amino Acid Analysis of BLV Whole-Genome Consensus Sequences
A comparative phylogenetic analysis was performed to investigate the genetic related-
ness of BLV genomes within related Holstein dams and adult daughters within a Michigan
dairy herd All the sequences were aligned with high accuracy and high throughput using
MUSCLE (MUltiple Sequence Comparison by Log- Expectation) with 64 iterations [42] (Na-
tional Center for Biotechnology Information, Bethesda, Maryland, USA). Phylogenetic trees
were constructed using maximum-likelihood (ML) methods [43] for each segment with
1000-bootstrap replications and GTR Gamma nucleotide substitution in RAXML v7.6.8,
utilizing the resources available at the Minnesota SuperComputing Institute. Trees were
rooted to the midpoint, with the increasing order of nodes. Tree topology was supported
by >70 bootstrap values. Bootstrap values below 70 were manually removed from the
trees using Adobe Illustrator CC 2018 (version 22.0.1 accessed on 7 March 2021). Trees
were visualized and depicted using FigTree (version 1.4.3 accessed on 7 March 2021). BLV
nucleotide sequences, translated to amino acids using Geneious Prime11.0.6 + 10, were
used to identify nonsynonymous mutations, if any, among the major proteins of BLV using
AP019598.1 as a reference genome.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
.3390/pathogens10091191/s1, Figure S1A: Map of the TOPO ® vector used with Corynebacterium
bovis and Mycoplasma bovis inserts, Figure S1B: Primary amplicon of the TOPO ® plasmids, gener-
ated from Topo-BLV primers (Table 1) used as a template for controls. Amplicon contains BLV seed
sequence for use as a positive control in the BLV PCR, Figure S1C: Electrophoretogram showing the
amplification, size, and integrity of TOPO ® plasmids encoding the 16s rDNA gene and Thioredoxin
gene from two different pathogens, respectively, used for Oxford Nanopore Sequencing. Figure S2:
Amino acid alignment of the ENV protein showing 100% identity between the animals studied. Only
sequences derived from BLV amplicons generated by CentralStar Laboratories were used for this
analysis. AP019598 is the Genbank accession number of the reference genome used for comparison.
Figure S3: Coverage plots generated on samples from Daughter 1 used to filter samples for further
data analysis. A: UMN generated amplicon. B: CentralStar group generated amplicon. Yellow areas
signify low coverage, and the colored vertical lines are SNPs when compared to the AP019598.1
reference genome.
Author Contributions: Conceptualization, C.J.D., D.C.S., and S.J.W.; methodology, L.A.P., J.N, and
S.K.M.; software, V.K.S. and S.M.G.; validation, L.A.P., J.N., and P.K.; formal analysis, J.N., V.K.S.,
and S.M.G.; investigation, L.A.P. and J.N.; resources, K.R.B.S. and T.M.T.; data curation, V.K.S., L.A.P.,
and J.N.; writing-original draft preparation, L.A.P. and J.N.; writing-review and editing, L.A.P.,
J.N., C.J.D., and S.J.W.; visualization, L.A.P. and J.N.; supervision, C.J.D., D.C.S., and S.J.W.; project
administration, C.J.D. and D.C.S.; funding acquisition, N/A. All authors have read and agreed to the
published version of the manuscript.
Funding: This research received no external funding.
Institutional Review Board Statement: Procedures for this study were reviewed and approved by
the Institutional Animal Care and Use Committee (A-3955-01, PROTO201900271) at Michigan State
University.
Informed Consent Statement: Not applicable.
Acknowledgments: We would like to acknowledge the support and guidance of Paul Bartlett, MPH,
DVM, as well as the invitation to submit our research into the BLV special issue.
Pathogens 2021, 10, 1191 14 of 15
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Gutiérrez, G.; Rodríguez, S.M.; De Brogniez, A.; Gillet, N.; Golime, R.; Burny, A.; Jaworski, J.P.; Alvarez, I.; Vagnoni, L.; Trono, K.;
et al. Vaccination against δ-Retroviruses: The Bovine Leukemia Virus Paradigm. Viruses 2014, 6, 2416–2427. [CrossRef] [PubMed]
2. Ladronka, R.M.; Ainsworth, S.; Wilkins, M.J.; Norby, B.; Byrem, T.M.; Bartlett, P.C. Prevalence of Bovine Leukemia Virus
Antibodies in US Dairy Cattle. Vet. Med. Int. 2018, 2018, 33–36. [CrossRef] [PubMed]
3. Bartlett, P.; Michigan State University. Bovine Leukemia Virus in the U.S.: Impact and Options for Control #1 What Is It? Why
Does It Matter? What Options for Control? Where to Start? What Can USAHA Do? Available online: https://blv.msu.edu/
resources/USAHA-Oct-16-2017.pdf (accessed on 14 September 2021).
4. Gao, A.; Kouznetsova, V.L.; Tsigelny, I.F. Bovine Leukemia Virus Relation to Human Breast Cancer: Meta-Analysis. Microb.
Pathog. 2020, 149, 104417. [CrossRef] [PubMed]
5. Buehring, G.C.; Delaney, A.; Shen, H.; Chu, D.L.; Razavian, N.; Schwartz, D.A.; Demkovich, Z.R.; Bates, M.N. Bovine Leukemia
Virus Discovered in Human Blood. BMC Infect. Dis. 2019, 19, 297. [CrossRef]
6. Aida, Y.; Murakami, H.; Takahashi, M.; Takeshima, S.N. Mechanisms of Pathogenesis Induced by Bovine Leukemia Virus as a
Model for Human T-Cell Leukemia Virus. Front. Microbiol. 2013, 4, 328. [CrossRef]
7. Kuczewski, A.; Mason, S.; Orsel, K.; van der Meer, F. Pilot Implementation of a Newly Developed Bovine Leukemia Virus Control
Program on 11 Alberta Dairy Farms. J. Dairy Sci. 2021, 104, 4549–4560. [CrossRef]
8. Ruiz, V.; Porta, N.G.; Lomónaco, M.; Trono, K.; Alvarez, I. Bovine Leukemia Virus Infection in Neonatal Calves. Risk Factors and
Control Measures. Front. Vet. Sci. 2018, 5, 1–7. [CrossRef]
9. Sajiki, Y.; Konnai, S.; Nishimori, A.; Okagawa, T.; Maekawa, N.; Goto, S.; Nagano, M.; Kohara, J.; Kitano, N.; Takahashi, T.; et al.
Intrauterine Infection with Bovine Leukemia Virus in Pregnant Dam with High Viral Load. J. Vet. Med. Sci. 2017, 79, 2036–2039.
[CrossRef]
10. Watanuki, S.; Takeshima, S.N.; Borjigin, L.; Sato, H.; Bai, L.; Murakami, H.; Sato, R.; Ishizaki, H.; Matsumoto, Y.; Aida, Y.
Visualizing Bovine Leukemia Virus (BLV)-Infected Cells and Measuring BLV Proviral Loads in the Milk of BLV Seropositive
Dams. Vet. Res. 2019, 50, 1–12. [CrossRef]
11. Mekata, H.; Sekiguchi, S.; Konnai, S.; Kirino, Y.; Honkawa, K.; Nonaka, N.; Horii, Y.; Norimine, J. Evaluation of the Natural
Perinatal Transmission of Bovine Leukaemia Virus. Vet. Rec. 2015, 176, 254. [CrossRef]
12. Juliarena, M.A.; Gutierrez, S.E.; Ceriani, C. Determination of proviral load in bovine leukemia virus–infected cattle with and
without lymphocytosis. Am. J. Vet. Res. 2007, 68, 1220–1225. [CrossRef] [PubMed]
13. Ruggiero, V.J.; Norby, B.; Benitez, O.J.; Hutchinson, H.; Sporer, K.R.B.; Droscha, C.; Swenson, C.L.; Bartlett, P.C. Controlling
Bovine Leukemia Virus in Dairy Herds by Identifying and Removing Cows with the Highest Proviral Load and Lymphocyte
Counts. J. Dairy Sci. 2019, 102, 9165–9175. [CrossRef]
14. Rola-Łuszczak, M.; Finnegan, C.; Olech, M.; Choudhury, B.; Kuźmak, J. Development of an Improved Real Time PCR for the
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